Company page
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. is a public company traded under the ticker MCRB in the American market. The company has a market capitalization of approximately $48 million. Seres focuses on developing microbiome-based therapeutics to treat various diseases.
- Ticker
- MCRB:NASDAQ
- Asset type
- Stock
- Market cap
- $50.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD